European Urology Supplements RSS feed: Articles in Press. Supplements to European Urology are published under the title European Urology Supplements (ISSN 1569-9056). All subscribers to European Urology automatically receive this publication. European Urology Supplements is the perfect publication vehicle for the proceedings of a scientific symposium, commissioned thematic issues, or for disseminating a selection of invited articles. What makes European Urology Supplements unique is the fact that it has impact factor of 2.358 (2009)* and sits within the widely respected European Urology family of urology publications published by Elsevier on behalf of the EAU and EBU. Publication History: Incorporating EAU-EBU Update Series. You can also visit the European Urology (ISSN 0302-2838) and EAU-EBU Update Series (ISSN 1570-9124).http://www.europeanurology-supplement.com//inpress?rss=yesElsevier Inc.en © 2010 Published by Elsevier Inc. European Urology Supplements1569-90562010-09-02 © 2010 Published by Elsevier Inc. healthpermissions@elsevier.comhttp://www.europeanurology-supplement.com/article/PIIS1569905610000801/abstract?rss=yesTake Home Message: This supplement provides an overview of the changing role of hormonal therapy for the palliative treatment of advanced and metastatic prostate cancer, focusing specifically on histrelin acetate (Vantas®), the first LH-RH agonist available as a once-yearly subcutaneous implant.Advances in Prostate Cancer Management: The First Once-Yearly Luteinising Hormone-Releasing Hormone Agonist - Corrected ProofJoan Palou10.1016/j.eursup.2010.08.001European Urology Supplements (2010)2010-09-02European Urology Supplements2010-09-02EDITORIALhttp://www.europeanurology-supplement.com/article/PIIS1569905606001254/abstract?rss=yesThis article has been removed, consistent with Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). The Publisher apologizes for any inconvenience this may cause.REMOVED: Evaluation of Vena Caval Tumour Thrombus with Intraoperative Ultrasound - Corrected ProofCarlo Trombetta, Giovanni Liguori, Giulio Garaffa, Stefano Bucci, Emanuele Belgrano10.1016/j.eursup.2006.03.006European Urology Supplements (2006)2006-05-01European Urology Supplements2006-05-01http://www.europeanurology-supplement.com/article/PIIS156990560600008X/abstract?rss=yesThe publisher regrets that this article is an accidental duplication of an article that has been published in Eur Urol 49 (2006) 937, doi:10.1016/j.eururo.2006.03.032. The duplicate article has therefore been withdrawn.WITHDRAWN: Corrigendum to: “How Good do Current LHRH Agonists Control Testosterone? Can this be Improved with Eligard®?” [European Urology Supplements 4/8 (2005) 1–41] - Corrected ProofBertrand Tombal, Richard Berges10.1016/j.eursup.2006.02.001European Urology Supplements (2006)2006-02-10European Urology Supplements2006-02-10